Cleared Traditional

K883826 - HOME CLINIC PREGNANCY TEST

K883826 is an FDA 510(k) clearance for HOME CLINIC PREGNANCY TEST, manufactured by Vanguard Biomedical Corp.. The device is a Class 2 Chemistry device with product code LCX cleared through the Traditional 510(k) pathway after a 81-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1988
Decision
81d
Days
Class 2
Risk

K883826 is an FDA 510(k) clearance for the HOME CLINIC PREGNANCY TEST. Classified as Kit, Test, Pregnancy, Hcg, Over The Counter (product code LCX), Class II - Special Controls.

Submitted by Vanguard Biomedical Corp. (San Diego, US). The FDA issued a Cleared decision on November 29, 1988 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vanguard Biomedical Corp. devices

FDA 510(k) Submission Details - K883826

510(k) Number K883826 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 1988
Decision Date November 29, 1988
Days to Decision 81 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 88d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCX Device Classification - Class 2, Special Controls

Product Code LCX Kit, Test, Pregnancy, Hcg, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LCX Kit, Test, Pregnancy, Hcg, Over The Counter

All 160
Devices cleared under the same product code (LCX) and FDA review panel - the closest regulatory comparables to K883826.
ABBOTT MODIFIED FACT PLUS PREGNANCY TEST
K901981 · Abbott Laboratories · Aug 1990
PERFECT(TM) ONE STEP EARLY PREGNANCY TEST KIT
K896482 · Pacific Biotech, Inc. · Mar 1990
PREGNA-CARD(TM) A VISUAL HOME PREGNANCY TEST
K883430 · Disease Detection International, Inc. · Jan 1989
DISCOVER(R)
K882232 · Carter Products · Oct 1988
BLUE DOT(TM) TEST FOR PREGNANCY
K882588 · V-Tech, Inc. · Oct 1988
CLEARBLUE EASY
K882416 · Unipath , Ltd. · Jul 1988